|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue, net | |||||
| Revenue under collaboration agreements | |||||
| Revenue under supply agreements | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Cost of goods sold (including related party amounts of $4,781 and $241, respectively) | |||||
| Research and development (including related party amounts of $2,255 and $2,066, respectively) | |||||
| General and administrative (including related party amounts of $940 and $603, respectively) | |||||
| Selling, general and administrative (including related party amounts of $475 and $465, respectively) | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense (including related party amounts of $130 and $0, respectively) | |||||
| Total other income, net | |||||
| Change in fair value of financial instruments | |||||
| (Loss) income before income tax (benefit) expense | |||||
| Income tax (benefit) expense | |||||
| Net (loss) income | |||||
| Unrealized (losses) gains on available-for-sale securities | |||||
| Comprehensive (loss) income | |||||
| Net (loss) income per share, basic | |||||
| Net income (loss) per share, Diluted | |||||
| Weighted- average common shares outstanding, basic | |||||
| Weighted Average Number of Shares Outstanding, Diluted | |||||
Loading...